ClinicalTrials.gov
public full text
Public Domain
A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer
An open-label, single-arm, multicenter, Phase Ib clinical trial to evaluate the efficacy and safety of CT041 Autologous CAR T Cell Injection after adjuvant chemotherapy in subjects with pancreatic cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- CAR T Cell Immunotherapy for Pancreatic Cancer#432902
- Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery#311194
- Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer#245557
- A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer#994893
- Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic Tumor#154739
Record · ID 879040
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive